Annamaria Colao to Octreotide
This is a "connection" page, showing publications Annamaria Colao has written about Octreotide.
Connection Strength
1.030
-
Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies. Endocrine. 2018 04; 60(1):65-72.
Score: 0.699
-
Poorly differentiated small cell neuroendocrine carcinoma localized in three different endocrine glands: response to chemotherapy and octreotide LAR. J Endocrinol Invest. 2005 Apr; 28(4):371-8.
Score: 0.073
-
Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab. 2001 Apr; 86(4):1551-7.
Score: 0.055
-
Therapeutic sequences in patients with grade 1-2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group. Endocrine. 2019 11; 66(2):417-424.
Score: 0.048
-
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab. 1998 Mar; 83(3):775-9.
Score: 0.045
-
Surgical debulking of pituitary adenomas improves responsiveness to octreotide lar in the treatment of acromegaly. Pituitary. 2017 Dec; 20(6):668-675.
Score: 0.044
-
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma? Endocrine. 2018 04; 60(1):15-27.
Score: 0.043
-
The management of the patient with acromegaly and headache: a still open clinical challenge. J Endocrinol Invest. 2008 Oct; 31(10):919-24.
Score: 0.023